WS #10587

From 500 msgs · 5 key-dev

Absci announces positive interim Phase 1 data for ABS-201 and prices $100M offering with Eli Lilly participation, a significant biotech catalyst.

Absci Positive Phase 1 Data and $100M Offering

Absci announces positive interim Phase 1 data for ABS-201 and prices $100M offering with Eli Lilly participation, a significant biotech catalyst.

Full world state #10587 →